Rating scales to measure side effects of antipsychotic medication: A systematic review

Journal of Psychopharmacology

Volumn 29, Issue 8, 2015, Pages 857-866

  Van Strien, Astrid M ^a   Keijsers, Carolina J P W ^a   Derijks, Hieronymus J ^b   Van Marum, Rob J ^a,c  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b Hospital Pharmacy ZANOB   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Antipsychotics; Application; Rating scales; Side effects; Systematic review; Validation

Indexed keywords

NEUROLEPTIC AGENT;

ABNORMAL INVOLUNTARY MOVEMENT SCALE; ABNORMAL KINETIC EFFECTS SCALE; AKATHISIA RATINGS OF MOVEMENT SCALE; AKATHISIA SCALE; ANTIPSYCHOTIC NON NEUROLOGICAL SIDE EFFECT; ANTIPSYCHOTICS AND SEXUAL FUNCTIONING QUESTIONNAIRE; APPROACHES TO SCHIZOPHRENIA COMMUNICATION; ARIZONA SEXUAL EXPERIENCE SCALE; ARTICLE; ASSOCIATION FOR METHODOLOGY AND DOCUMENTATION IN PSYCHIATRY PSYCHOTROPIC SIDE EFFECT RATING SCALE; AUSTRALIAN SURVEY OF CHAN FOR PARKINSONISM; BARNES AKATHISIA SCALE; CHANGES IN SEXUAL FUNCTION QUESTIONNAIRE 14; COLOMBIA UNIVERSITY RATING SCALE; CONSISTENCY ACROSS METHODS OF PREFERENCE ASSESSMENT; CORNELL UNIVERSITY RATING SCALE FOR PARKINSONISM; DEROGATIS INTERVIEW FOR SEXUAL FUNCTION; DIMASCIO EXTRAPYRAMIDAL SYMPTOM SCALE; DISTRESS SCALE FOR ADVERSE SYMPTOM; DRUG INDUCED EXTRAPYRAMIDAL SYMPTOMS SCALE; DYSKINESIA IDENTIFICATION SYSTEM CONDENSED USER SCALE; EPWORTH SLEEPINESS SCALE; EXTRAPYRAMIDAL SYMPTOM; EXTRAPYRAMIDAL SYMPTOM RATING SCALE; FOOD CRAVING INVENTORY; GLASGOW ANTIPSYCHOTIC SIDE EFFECT SCALE; GLOBAL INDEX OF SAFETY; HILLSIDE AKATHISIA SCALE; HUMAN; INTERNATIONAL RESTLESS LEGS SCALE; INTERRATER RELIABILITY; INTRARATER RELIABILITY; KLAWANS SCALE FOR EXTRAPYRAMIDAL SYMPTOM; LIVERPOOL UNIVERSITY NEUROLEPTIC SIDE EFFECT RATING SCALE; LONG INSTRUMENT FOR DIAGNOSIS OF DRUG INDUCED AKATHISIA; MARYLAND PSYCHIATRIC RESEARCH CENTER SCALE; MATSON EVALUATION OF DRUG SIDE EFFECT; MINDHAM; NAGOYA SEXUAL FUNCTION QUESTIONNAIRE; NAGOYA SEXUAL FUNCTIONING QUESTIONNAIRE; PERG SURVEY FOR PARKINSONISM; PRINCE HENRY HOSPITAL AKATHISIA RATING SCALE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOTROPIC RELATED SEXUAL DYSFUNCTION QUESTIONNAIRE; RATING SCALE; RATING SCALE FOR EXTRAPYRAMIDAL SIDE EFFECT; ROCKLAND SIMPSON DYSKINESIA SCALE; SCHEDULE FOR THE ASSESSMENT OF DRUG INDUCED MOVEMENT DISORDER; SEXUAL DYSFUNCTION; SEXUAL FUNCTION QUESTIONNAIRE; SIDE EFFECT ASSESSMENT; SIMPSON-ANGUS SCALE; ST. HANS RATING SCALE FOR EXTRAPYRAMIDAL SYNDROME; SUBJECTIVE SIDE EFFECT SCALE; SUBJECTS RESPONSE TO ANTIPSYCHOTIC; SYSTEMATIC MONITORING OF ADVERSE EVENTS RELATED TO TREATMENT; SYSTEMATIC REVIEW; TARDIVE DYSKINESIA RATING SCALE; TARDIVE DYSKINESIA VIDEOTAPE RATING TECHNIQUE; TEST RETEST RELIABILITY; TOLERABILITY AND QUALITY OF LIFE; UDVALG FOR KLINISKE UNDERSOGELSER SIDE EFFECTS RATING SCALE FOR CLINICIAN; UDVALG FOR KLINISKE UNDERSOGELSER SIDE EFFECTS RATING SCALE FOR PATIENT; UNIFIED PARKINSON DISEASE RATING SCALE; VALIDATION STUDY; YALE EXTRAPYRAMIDAL SYMPTOM SCALE; DEVICES; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; QUESTIONNAIRE;

ANTIPSYCHOTIC AGENTS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; HUMANS; PSYCHOMETRICS; SURVEYS AND QUESTIONNAIRES;

EID: 84937953183     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881115593893     Document Type: Article

References (59)

1. Barnes TR, (1989) A rating scale for drug-induced akathisia. Br J Psychiatry 154: 672-676.
2. Barnes TR, (2003) The Barnes Akathisia Rating Scale-revisited. J Psychopharmacol 17: 365-370.
3. Barnes TR, Trauer T, (1982) Reliability and validity of a tardive dyskinesia videotape rating technique. Br J Psychiatry 140: 508-515.
4. Byerly MJ, Nakonezny PA, Fisher R,. (2006) An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder. Schizophr Res 81: 311-316.
5. Cassady SL, Thaker GK, Summerfelt A,. (1997) The Maryland Psychiatric Research Center scale and the characterization of involuntary movements. Psychiatry Res 70: 21-37.
6. Chouinard G, Margolese HC, (2005) Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr Res 76: 247-265.
7. Cicchetti DV, (1994) Multiple comparison methods: Establishing guidelines for their valid application in neuropsychological research. J Clin Exp Neuropsychol 16: 155-161.
8. Cohen J, (1968) Weighted kappa: Nominal scale agreement with provision for scaled disagreement or partial credit. Psychol Bull 70: 213-220.
9. Day JC, Kinderman P, Bentall R, (1998) A comparison of patients' and prescribers' beliefs about neuroleptic side-effects: Prevalence, distress and causation. Acta Psychiatr Scand 97: 93-97.
10. Day JC, Wood G, Dewey M,. (1995) A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. Br J Psychiatry 166: 650-653.
11. De Araujo AA, de Araujo, Dantas D, do Nascimento GG,. (2014) Quality of life in patients with schizophrenia: The impact of socio-economic factors and adverse effects of atypical antipsychotics drugs. Psychiatr Q 85: 357-367.
12. De Boer MK, Castelein S, Bous J,. (2013) The Antipsychotics and Sexual Functioning Questionnaire (ASFQ): Preliminary evidence for reliability and validity. Schizophr Res 150: 410-415.
13. De Boer MK, Castelein S, Wiersma D,. (2014) A systematic review of instruments to measure sexual functioning in patients using antipsychotics. J Sex Res 51: 383-389.
14. Garcia MJ, Matson JL, (2008) Akathisia in adults with severe and profound intellectual disability: A psychometric study of the MEDS and ARMS. J Intellect Dev Disabil 33: 171-176.
15. Garcia-Portilla MP, Saiz PA, Fonseca E,. (2011) Psychometric properties of the Spanish version of the Changes in Sexual Functioning Questionnaire Short-Form (CSFQ-14) in patients with severe mental disorders. J Sex Med 8: 1371-1382.
16. Gerlach J, Korsgaard S, Clemmesen P,. (1993) The St. Hans Rating Scale for extrapyramidal syndromes: Reliability and validity. Acta Psychiatr Scand 87: 244-252.
17. Haddad PM, Fleischhacker WW, Peuskens J,. (2014) SMARTS (Systematic Monitoring of Adverse events Related to TreatmentS): The development of a pragmatic patient-completed checklist to assess antipsychotic drug side effects. Ther Adv Psychopharmacol 4: 15-21.
18. Janno S, Holi MM, Tuisku K,. (2005a) Actometry and Barnes Akathisia Rating Scale in neuroleptic-induced akathisia. Eur Neuropsychopharmacol 15: 39-41.
19. Janno S, Holi MM, Tuisku K,. (2005b) Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population. BMC Neurol 5: 5.
20. Jung HY, Kim JH, Ahn YM,. (2005) Liverpool University Neuroleptic Side-Effect Rating Scale (LUNSERS) as a subjective measure of drug-induced parkinsonism and akathisia. Hum Psychopharmacol 20: 41-45.
21. Kalachnik JE, Sprague RL, (1993) The Dyskinesia Identification System Condensed User Scale (DISCUS): Reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations. J Clin Psychol 49: 177-189.
22. Kikuchi T, Iwamoto K, Sasada K,. (2011) Reliability and validity of a new sexual function questionnaire (Nagoya Sexual Function Questionnaire) for schizophrenic patients taking antipsychotics. Hum Psychopharmacol 26: 300-306.
23. Kim JH, Choi SW, Joe SH,. (2008) Reliability and validity of the Korean version of UKU-SERS-Pat in patients with bipolar disorder. Nord J Psychiatry 62: 496-502.
24. Kim JH, Jung HY, Kang UG,. (2002) Metric characteristics of the Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS): A practical combined rating scale for drug-induced movement disorders. Mov Disord 17: 1354-1359.
25. Knol W, Keijsers CJ, Jansen PA,. (2009) Validity and reliability of the Simpson-Angus Scale (SAS) in drug induced parkinsonism in the elderly. Int J Geriatr Psychiatry 24: 183-189.
26. Knol W, Keijsers CJ, Jansen PA,. (2010) Systematic evaluation of rating scales for drug-induced parkinsonism and recommendations for future research. J Clin Psychopharmacol 30: 57-63.
27. Knol W, van Marum RJ, Jansen PA,. (2012) Parkinsonism in elderly users of haloperidol: Associated with dose, plasma concentration, and duration of use. J Clin Psychopharmacol 32: 688-693.
28. Lambert TJ, Cock N, Alcock SJ,. (2003) Measurement of antipsychotic-induced side effects: support for the validity of a self-report (LUNSERS) versus structured interview (UKU) approach to measurement. Hum Psychopharmacol 18: 405-411.
29. Lenert LA, Morss S, Goldstein MK,. (1997) Measurement of the validity of utility elicitations performed by computerized interview. Med Care 35: 915-920.
30. Lindstrom E, Lewander T, Malm U,. (2001) Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat). Nord J Psychiatry 55 (Suppl 44): 5-69.
31. Lingjaerde O, Ahlfors UG, Bech P, (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76: 1-100.
32. Loonen AJ, Doorschot CH, van Hemert DA,. (2000) The Schedule for the Assessment of Drug-Induced Movement Disorders (SADIMoD): Test-retest reliability and concurrent validity. Int J Neuropsychopharmacol 3: 285-296.
33. Loonen AJ, Doorschot CH, van Hemert DA,. (2001) The schedule for the assessment of drug-induced movement disorders (SADIMoD): Inter-rater reliability and construct validity. Int J Neuropsychopharmacol 4: 347-360.
34. Loonen AJ, van Praag HM, (2007) Measuring movement disorders in antipsychotic drug trials: The need to define a new standard. J Clin Psychopharmacol 27: 423-430.
35. Mahmoud A, Drake RJ, Lewis SW,. (2011) The ANNSERS (Antipsychotic Non-Neurological Side Effects Rating Scale): Validation of sexual side-effect measurement. Ther Adv Psychopharmacol 1: 97-100.
36. Mazure CM, Cellar JS, Bowers MB Jr,. (1995) Assessment of extrapyramidal symptoms during acute neuroleptic treatment. J Clin Psychiatry 56: 94-100.
37. McCann TV, Clark E, Lu S, (2009) Subjective side effects of antipsychotics and medication adherence in people with schizophrenia. J Adv Nurs 65: 534-543.
38. McGahuey CA, Gelenberg AJ, Laukes CA,. (2000) The Arizona Sexual Experience Scale (ASEX): Reliability and validity. J Sex Marital Ther 26: 25-40.
39. Mindham RH, (1976) Assessment of drugs in schizophrenia. Assessment of drug-induced extrapyramidal reactions and of drugs given for their control. Br J Clin Pharmacol 3: 395-400.
40. Moher D, Liberati A, Tetzlaff J,. (2009) Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ 339: b2535.
41. Montejo AL, Correas-Lauffer J, Maurino J,. (2011) Estimation of a multiattribute utility function for the Spanish version of the TooL questionnaire. Value Health 14: 564-570.
42. Montejo AL, Rico-Villademoros F, (2008) Psychometric properties of the Psychotropic-Related Sexual Dysfunction Questionnaire (PRSexDQ-SALSEX) in patients with schizophrenia and other psychotic disorders. J Sex Marital Ther 34: 227-239.
43. Munetz MR, Benjamin S, (1988) How to examine patients using the Abnormal Involuntary Movement Scale. Hosp Community Psychiatry 39: 1172-1177.
44. Ohlsen RI, Williamson R, Yusufi B,. (2008) Interrater reliability of the Antipsychotic Non-Neurological Side-Effects Rating Scale measured in patients treated with clozapine. J Psychopharmacol 22: 323-329.
45. Prieto L, Sacristan JA, Gomez JC, (2004) The validity and reliability of the global index of safety (GIS). Curr Med Res Opin 20: 1825-1832.
46. Sachdev P, (1994) A rating scale for acute drug-induced akathisia: Development, reliability, and validity. Biol Psychiatry 35: 263-271.
47. Sacristan JA, Gomez JC, Badia X,. (2001) Global index of safety (GIS): A new instrument to assess drug safety. J Clin Epidemiol 54: 1120-1125.
48. Sarfati Y, Olivier V, Bouhassira M, (1999) New antipsychotics in the treatment of schizophrenia. A European survey. Encephale 25: 658-666.
49. Schouten HJ, Knol W, Egberts TC,. (2012) Quality of life of elderly patients with antipsychotic-induced parkinsonism: A cross-sectional study. J Am Med Dir Assoc 13: 82.e1-82.e5.
50. Seitz DP, Gill SS, van Zyl LT, (2007) Antipsychotics in the treatment of delirium: A systematic review. J Clin Psychiatry 68: 11-21.
51. Simpson GM, Angus JW, (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212: 11-19.
52. Sprague RL, Korach MS, van Emmerik RE,. (1993) Correlations between kinematic and rating scale measures of tardive dyskinesia in a developmentally disabled population. J Nerv Ment Dis 181: 42-47.
53. Sprinthall R, (2012) Basic Statistical Analysis. Boston: Allyn & Bacon.
54. Suzuki T, (2011) Which rating scales are regarded as 'the standard' in clinical trials for schizophrenia? A critical review. Psychopharmacol Bull 44: 18-31.
55. Tonelli H, Tonelli D, Poiani GR,. (2003) Reliability and clinical utility of a Portuguese version of the Abnormal Involuntary Movements Scale (AIMS) for tardive dyskinesia in Brazilian patients. Braz J Med Biol Res 36: 511-514.
56. Vinson DR, (2006) Development of a simplified instrument for the diagnosis and grading of akathisia in a cohort of patients receiving prochlorperazine. J Emerg Med 31: 139-145.
57. Waddell L, Taylor M, (2008) A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. J Psychopharmacol 22: 238-243.
58. Weiden PJ, Miller AL, (2001) Which side effects really matter? Screening for common and distressing side effects of antipsychotic medications. J Psychiatr Pract 7: 41-47.
59. Wolters HA, Knegtering R, Wiersma D,. (2006) Evaluation of the Subjects' Response to Antipsychotics Questionnaire. Int Clin Psychopharmacol 21: 63-69.